Uloga interleukina-6 u patogenezi hroničnih periapeksnih lezija by Popović, Jelena et al.
126 Serbian Dental Journal, vol. 65, No 3, 2018
ORIGINAL ARTICLE  DOI: 10.2478/sdj-2018-0012
ORIGINALNI RAD  UDC: 616.314.165-002
Address for correspondence: Jelena POPOVIĆ, Clinic of Dentistry, Department of Restorative Dentistry and Endodontics, 
Blvd. Dr Zorana Djindjića 52, 18000 Niš; jelenadp@gmail.com
The role of interleukin-6 in pathogenesis of chronic 
periapical lesions
Jelena Popović1, Tatjana Cvetković2, Tanja Džopalić3, Marija Nikolić1, Aleksandar Mitić1, 
Radomir Barac1, Slavoljub Živković4
1University of Niš, Faculty of Medicine, Clinic of Dentistry, Department of Restorative Dentistry and Endodontics, Niš, Serbia;
2University of Niš, Faculty of Medicine, Institute of Biochemistry, Niš, Serbia;
3University of Niš, Faculty of Medicine, Institute of Immunology, Niš, Serbia;
4University of Belgrade, School of Dental Medicine, Clinic of Restorative Odontology and Endodontics, Belgrade, Serbia
SUMMARY
Introduction Cytokine network plays an important role in pathogenesis of chronic periapical lesions. The aim of this 
study was to determine the concentration of interleukin-6 (IL-6) in tissue homogenates of human periapical lesions 
and correlate its levels with symptomatology and size of the lesions.
Materials and Methods 93 samples of chronic periapical lesions were obtained after extraction of teeth. Samples were 
divided according to the clinical presentation as symptomatic and asymptomatic, and according to the size as large 
and small. The concentration of IL-6 was analyzed using ELISA.
Results Statistically significant difference in IL-6 concentration was observed in symptomatic lesions compared to 
asymptomatic (p<0.001). Analysis showed statistically higher concentration in large symptomatic lesions compared 
to large asymptomatic lesions (p<0.001), and in small symptomatic lesions compared to small asymptomatic (p<0.05). 
Higher production of IL-6 was observed in large lesions compared to small but this difference was not statistically 
significant.
Conclusion Higher concentration of IL-6 in lesions with expressed clinical symptoms as well as in large lesions indicates 
that IL-6 is an important factor responsible for the progression of lesions and bone resorption.
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INTRODUCTION
Periapical lesions are inflammatory disorders that develop 
as a result of an immune response to continuous antigen 
stimulation from the root canal. Their development and 
progression to chronic lesions with concomitant bone 
resorption occur as a result of inability of host defense 
mechanisms to remove infection [1]. Chronic periapical 
lesions represent inflamed granulation tissue infiltrated 
by different inflammatory cells, which produce a variety of 
mediators. Cytokine network plays an important role in the 
regulation of non-specific and specific immune responses. 
Many studies have demonstrated the production of various 
cytokines in the periapical lesions [2, 3].
Interleukin 6 (IL-6) is a cytokine that influences the 
antigen-specific immune responses and inflammatory 
reactions, and has the role of proinflammatory and anti-
inflammatory cytokine [4]. IL-6 is the “myokin”, a cyto-
kine produced in the muscles in response to contraction. 
It increases significantly with exercise, and prior to the 
occurrence of other cytokines in the bloodstream. IL-6 
production is proven in human periapical lesions [5] and 
in marginal inflamation of periodontal tissues [6]. The lit-
erature data suggests that IL-6 is multifunctional cytokine 
produced by several types of immune cell- monocytes, 
macrophage, Th-2 cells, activated B cells, and polymor-
phonuclear cells [7]. Production of IL-6 is carried out 
under the influence of IL-1, TNF-α and INF-γ, however, 
it also regulates the secretion of IL-1 and is opposed by 
some of its effects. IL-6 is secreted by osteoblasts dur-
ing stimulation of osteoclast formation. IL-6 stimulates 
the formation of osteoclast precursors and increases the 
number of osteoclasts in vivo, leading to systematic bone 
resorption [8]. Along with TNF-α and IL-1, it belongs to 
the group of major proinflammatory cytokines. Numerous 
data indicate that IL-6 also has anti-inflammatory activity. 
The antiinflammatory role of IL-6 is mediated through 
the inhibitory effects of TNF-α and IL-1 [9].
The aim of this study was to determine the concen-
tration of interleukin-6 (IL-6) in tissue homogenates of 
human periapical lesions and correlate its levels with 
symptomatology and size of the lesions.
MATERIALS AND METHODS
The study included 93 patients from the Clinic of Den-
tistry, Nis, who were diagnosed with chronic periapical le-
sions using clinical and radiographic methods. The study 
was approved by the Ethical Committee of the Medical 
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Faculty, University of Nis, Serbia (no. 01-2066-5). Periapi-
cal lesions were collected from teeth that were determined 
as non-salvageable and indicated for extraction. 
From each patient, dental history including symptom-
atology and medications was collected and clinical exam 
was performed. Other inclusion criteria were healthy pa-
tients not suffering from acute or chronic diseases that 
could lead to immunodeficiency, and who were not taking 
antibiotics and anti-inflammatory medications in the last 
two months. 
Only teeth with periapical lesions that did not show 
moderate or severe form of marginal periodontitis were 
included in the study. According to subjective symptoms 
of patients, lesions were divided into the two groups: 
symptomatic and asymptomatic. Clinically symptomatic 
lesions were characterized by swelling, pain, discomfort 
when chewing or sensitivity to percussion and palpation 
whereas asymptomatic lesions showed no symptoms. The 
size of periapical lesions was measured in millimeters us-
ing a ruler and divided into the two groups: small (≤5 
mm) and large (≥6 mm) (Table 1). Since periapical lesions 
contain granulomatous inflammatory tissue that replaces 
normal bone there was no equivalent tissue that could be 
used as negative control. 
Before administering local anaesthetics, teeth, gingiva 
and mucosa around the tooth were cleaned using 0.12% 
chlorhexidine and the patient rinsed mouth with 0.12% 
chlorhexidine for 30 seconds. Samples of periapical le-
sions removed from the root apex were collected immedi-
ately after the extraction using sterile scalpel, then washed 
in sterile saline solution, dried with sterile cotton, placed 
in a sterile plastic Eppendorf tubes and frozen at -70°C. 
Using teflon crusher in an iced phosphate buffer at pH 
7.4, samples were homogenized with volume adapted to 
weight of the tissue obtaining the final concentration of 
10%. Larger debris was sedimented by centrifugation at 
1400 rpm for 1 minute at -40°C. The supernatant was fro-
zen at -70°C until further analysis was performed.
The concentration of IL-6 was measured using ELISA 
test (R&D Systems Inc. Minneapolis, USA) according to 
the manufacturer’s instructions. The sensitivity of ELISA 
test for IL-6 was from 0.7 pg/ml, and the concentration of 
cytokine was analyzed in relation to the size and symp-
tomatology of periapical lesions. Statistical analysis was 
performed using the Mann-Whitney Rank Sum test in the 
software Sigmastat and Origin. The results were expressed 
as mean ± standard deviation. P<0.05 was considered sta-
tistically significant.
RESULTS
All tissue homogenates of periapical lesions showed signifi-
cant concentration of IL-6 cytokine. Figure 1 shows the con-
centration of IL-6 in the tissue homogenates of all samples 
that were analyzed with respect to the size and symptom-
atology. In symptomatic lesions average concentration of 
IL-6 was 975.51 pg/ml, while in the group of asymptomatic 
lesions the average value was 212.04 pg/ml. Analysis of the 
concentration showed that there was significantly higher 
concentration of IL-6 in symptomatic lesions (p<0.001). In 
the group of large lesions, average concentrations of IL-6 
amounted to 687.14 pg/ml, while in the group of small le-
sions average value was 470.92 pg/ml. The difference was 
observed but not statistically significant.
Table 2 shows the concentration of IL-6 within the 
group of symptomatic and asymptomatic lesions, and 
the concentration of cytokines in each of the groups were 
analyzed with respect to the size. The average concentra-
tion of IL-6 in the large symptomatic lesions amounted 
to 1162.40 pg/ml, while in the small symptomatic lesions 
it was 759.11 pg/ml. A statistically significant difference 
in the concentrations of IL-6 was not observed in the 
symptomatic lesions in relation to the size. In the group 
of asymptomatic lesions, statistically significant differ-
Table 1. Periapical lesions according to symptomatology and size




















Table 2. IL-6 concentration in symptomatic and asymptomatic le-
sions






Mean ±  SD






Velike lezije 22 1162.40±1002,40 884.90 8.79-2649.63
Small lesions




Velike lezije 21 189.24±205.39 74.90 27.35-759.62
Small lesions
Male lezije 23 232.86±408.21 107.57 11.07-1670.97
Figure 1. Concentration of IL-6 in tissue homogenates of periapical 
lesions in relaton to symptomatology and size
SLika 1. Koncentracija IL-6 u homogenatu tkiva periapeksnih lezija 
u odnosu na simptomatologiju i veličinu
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ence in concentration of IL-6 was also not observed in 
relation to the size. The average concentration of IL-6 in 
large asymptomatic lesions amounted to 189.24 pg/ml, 
while in small asymptomatic lesions it was 232.86 pg/ml.
Figure 2 shows the concentration of IL-6 in the groups 
of large and small lesions where the statistical significance 
was analyzed in relation to symptomatology. The aver-
age concentration of IL-6 in large symptomatic lesions 
amounted to 1162.40 pg/ml, while in large asymptomatic 
lesions it was 189.24 pg/ml. The difference was statisti-
cally significant (p<0.001). The analysis showed signifi-
cantly higher concentration in small symptomatic (759.11 
pg/ml) compared to small asymptomatic lesions (232.86 
pg/ml) (p<0.05).
DISCUSSION
Periapical lesions develop as a result of persistent inflam-
matory response induced by prolonged exposure of peri-
apical tissue to root canal microorganisms, causing an im-
mune reaction. In this local defense mechanism different 
inflammatory mediators play a complex and central role 
in the regulation of immune response. While proinflam-
matory cytokines, such as IL-1, IL-6, TNF-α, TNF-β, che-
mokines and Th1 cytokines, promote inflammation in the 
periapical tissues and activate osteoclastic bone resorption 
[10, 11], the role of antiinflammatory cytokines is impor-
tant for suppression of inflammatory processes and repair 
processes within the periapical lesions [2, 3, 12].
In the early inflammatory cascade IL-1 and TNF-α in-
duce production of IL-6. IL-6 has many molecular forms, 
and each molecule has a different function if secreted 
by various cells in different situations. The finding that 
polymorphonuclear cells in the periapical tissues produce 
IL-6, which was specified by the Euler et al. [13], suggest 
that IL-6 can contribute to the tissue injury at the site of 
inflammation. IL-6 is an integral mediator of the acute 
phase response to injury and infection that stimulate ex-
pression of acute phase protein [14]. Examination of vari-
ous cytokines, such as TNF-α, IL-6, IL-3, GM-CSF, IL-11, 
IL-17, IL-18, in human and animal models have demon-
strated their potential role in the pathogenesis of osteo-
lytic diseases [2, 15]. It has been shown that inflamma-
tory cytokines IL-6 and TNF-α have the capacity to trigger 
osteoclastic bone resorption and their role can express 
synergistically with IL-1, causing activation or osteoclast 
differentiation and production, as well as secretion of 
prostaglandins by numerous cell types, including fibro-
blasts and osteoblasts [2]. Several authors have published 
the expression of IL-6 production in human periapical 
granulomas and cysts. Results of our study showed the 
presence of IL-6 in all tissue samples of periapical lesions 
that is in accordance with data from the literature [9, 16].
Studies have shown that the level of IL-6 is significant-
ly increased in the infection and pain conditions. In the 
study of De Jongh et al. [17] important role is attributed 
to IL-6 in the pathophysiology of pain. Due to this fact, 
in our study we analyzed correlation between levels of 
IL-6 and symptomatology. The results of our investiga-
tions indicated statistically significant difference in IL-6 
production in the symptomatic compared to asymptom-
atic lesions, while the average concentration of cytokines 
was higher in the large lesions compared to small, but the 
difference was not statistically significant.
The study of Gazivoda et al. [18] showed higher pro-
duction of IL-6 in symptomatic and large lesions primar-
ily emphasizing its proinflammatory aspect. However, 
experiments on IL-6-deficient mice showed conflicting 
results, indicating protective effect of this cytokine to 
bone destruction [14]. These differences may be explained 
by the fact that IL-6 has both proinflammatory and antiin-
flammatory role and its final effect depends on the target 
cells and coordination with additional cytokines.
Inflammatory reaction in patients with apical peri-
odontitis is not limited to periradicular region [19]. It is 
known that dental infection can have negative impact on 
general health in patients with risk [20]. Blood analysis in 
patients after endodontic treatment of teeth with apical 
periodontitis showed the presence of bacteria that origi-
nate from root canal [21]. Spreading oral bacteria through 
the bloodstream is not the only way for mediation-target-
ed effects of oral focal infections. More significant effect 
on distant tissues and organs function may be induced by 
certain cytokines. Although the majority of members of 
the cytokine superfamily exhibits short-term effects, IL-
1, IL-6 and TNF have been shown that locally produced 
within the tissues of periapical granulomas, can be car-
ried by the bloodstream to distant places. These cytokines 
can cause acute phase response, which includes fever, 
increased erythrocyte sedimentation rate, and change 
in serum proteins synthesized by hepatocytes. Some au-
thors examined elevated levels of acute phase protein in 
patients with chronic periapical granulomas. Their level 
was lowered to the normal value after the surgical removal 
of lesions by apicoectomy [10, 22].
CONCLUSIONS
High concentration of IL-6 in lesions with expressed 
clinical symptoms, as well as in large lesions, indicate 
its important pro-inflammatory activity and key role of 
Figure 2. IL-6 concentration in large and small lesions
Slika 2. Koncentracija IL-6 u okviru grupa velikih i malih lezija
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strong mediator responsible for the progression of lesion 
and stimulation of bone resorption in the pathogenesis of 
periapical lesions. 
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KRATAK SADRŽAJ
Uvod Mreža citokina igra značajnu ulogu u patogenezi hroničnih periapeksnih lezija. Cilj studije je bio da se odredi koncentracija 
IL-6 u tkivnim homogenatima hroničnih periapeksnih lezija i da se proveri korelacija sa simptomatologijom i veličinom lezija.
Materijal i metode Ispitana su 93 uzorka hroničnih periapeksnih lezija dobijenih nakon ekstrakcije zuba. Uzorci lezija su podeljeni 
prema simptomatologiji pacijenata na simptomatske i asimptomatske, a prema veličini na velike i male. Koncentracija IL-6 je ispi-
tivana pomoću ELISA testa, a dobijene vrednosti su analizirane u odnosu na grupe. 
Rezultati Statistički značajna razlika u koncentraciji IL-6 je uočena u grupi simptomatskih lezija u poređenju sa asimptomatskim 
(p < 0,001). Analiza je pokazala i statistički značajno veću koncentraciju u velikim simptomatskim lezijama u odnosu na velike 
asimptomatske (p < 0,001) i u malim simptomatskim lezijama u odnosu na male asimptomatske (p < 0,05). Zapažena je i povećana 
produkciju IL-6 u velikim lezijama u odnosu na male, međutim, razlika nije bila statistički značajna. 
Zaključak Veća koncentracija IL-6 u lezijama sa izraženim kliničkim simptomima kao i velikim lezijama ukazuje na njegovu važnu 
ulogu u progresiji periapeksnih lezija i koštane resorpcije.
Ključne reči: periapeksne lezije; citokini; IL-6
UVOD
Periapeksne lezije su inflamatorna oboljenja koja nastaju kao 
rezultat imunog odgovora na kontinuiranu antigenu stimulaciju 
iz kanala korena. Njihov razvoj i progresija u hronične lezije sa 
posledičnim gubitkom kosti nastaju kao rezultat nemogućnosti 
mehanizama odbrane domaćina da ukloni infekciju [1]. Tkivo 
hroničnih periapeksnih lezija predstavlja inflamirano granula-
ciono tkivo infiltrisano različitim inflamatornim ćelijama koje 
produkuju brojne medijatore. Mreža citokina ima značajnu 
ulogu u regulisanju nespecifičnih i specifičnih imunih odgo-
vora. Mnoge studije su dokazale produkciju različitih citokina 
u periapeksnim lezijama [2, 3].
Interleukin 6 (IL-6) je citokin koji utiče na antigen-specifične 
imune odgovore i inflamatorne reakcije i ima ulogu i proinfla-
matornog i antiinflamatornog citokina [4]. IL-6 je i „miokin“, 
citokin produkovan u mišićima u odgovoru na mišićnu kontrak-
ciju. Značajno se povećava vežba njem, a prethodi i pojavi drugih 
citokina u cirkulaciji. IL-6 je doka zan u humanim periapeksnim 
lezijama [5] i u inflamiranim marginalnim parodontalnim tkivi-
ma [6]. Podaci iz literature govore da je IL-6 multifunkcionalni 
citokin koga produkuje nekoliko tipova imunih ćelija – monociti, 
maktofagi, Th-2 limfociti, aktivirane B ćelije i polimorfonuklear-
ne ćelije [7]. Produkcija IL-6 se odvija pod uticajem IL-1, TNF-α i 
INF-γ, međutim, on istovremeno reguliše sekreciju IL-1 i suprot-
stavlja se nekim njegovim efektima. IL-6 sekretuju i osteoblasti 
prilikom stimulisanja osteoklastne formacije. IL-6 stimuliše for-
miranje osteoklastnih prekursora i povećava broj osteoklasta in 
vivo, dovodeći do sistemskog pojačanja koštane resorpcije [8]. 
Zajedno sa TNF-α i IL-1, pripada grupi glavnih proinflamatornih 
citokina. Brojni podaci pokazuju da IL-6 poseduje i antiinfla-
matorne aktivnosti. Uloga IL-6 kao antiin fla matornog citokina 
posreduje kroz inhibitorne efekte TNF-α i IL-1 [9]. 
Cilj ove studije je bio da se odredi koncentracija IL-6 u ho-
mogenatima tkiva periapeksnih lezija i da se proveri korelacija 
sa simptomatologijom i veličinom lezija.
MATERIJAL I METODE
U istraživanje su bila uključena 93 pacijenta Klinike za stoma-
tologiju Medi cinskog fakulteta u Nišu kod kojih je kliničkim i 
radiografskim metodama postav ljena dija gnoza hro nične pe-
riapeksne lezije. Studija je odobrena od strane Etičkog odbora 
Medicinskog fakulteta u Nišu (br. 01-2066-5). Periapeksne lezije 
analizirane u studiji uzimane su sa korenova zuba koji su zbog 
nemogućnosti lečenja indikovani za ekstrakciju. Od svakog 
pacijenta su uzimani anamnes tički podaci o toku i trajanju 
oboljenja, simptomatologiji, uzimanju lekova, a inspekcijom i 
palpacijom je utvrđeno eventualno postojanje lokalnog otoka ili 
otoka limf nih žlezda. Pored prisustva periapeksne lezije, uslov 
za uključenje pacijenata u stu di ju je bio da ne boluju od akutnih 
ili hroničnih oboljenja koja dovode do stanja imuno deficijencije 
i da u prethodna dva meseca nisu uzimali antibiotsku i antiin-
fla ma tornu terapiju. U istraživanje su uključivane peri apeksne 
lezije onih zuba koji nisu pokazivali umeren ili ozbiljan oblik 
marginalnog paro dontitisa.
Ispitivane lezije su prema subjektivnim simptomima pacije-
nata bile podeljene u dve grupe – simptomatske i asimptomatske 
lezije. Klinički su se simptomatske lezije ka rak terisale otokom, 
bolom, nelagodnošću pri žvakanju ili osetljivošću na perkusiju 
i pal pa ciju, dok asimpto matske lezije nisu pokazivale znake ili 
simptome akutnih peri a peksnih oboljenja u vreme studije. Peri-
apeksne lezije su merene milimetarskim lenjirom i u odnosu na 
veličinu pode lje ne u dve grupe: male (≤ 5 mm) i velike (≥ 6mm) 
(Tabela 1). S obzi rom na to da periapeksne lezije obuhvataju 
reaktivno tkivo koje se sastoji uglavnom od gra nulomatoznog 
inflamatornog tkiva koje zamenjuje normalnu kost, nije posto-
jao pravi tkivni ekvivalent koji bi služio kao nega tivna kontrola. 
Pre davanja lokalnog anestetika, zubi, gingiva i sluzokoža oko 
zuba su očišćeni 0,12% hlorheksidinom, a pacijent je ispirao 
usta 0,12% hlorheksidinom 30 sekundi. Uzorci periapeksnih 
lezija su odmah po ekstrakciji sterilnim skalpelom odstranjeni 
sa vrha korena zuba, isprani u sterilnom fiziološkom rastvoru, 
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prosušeni na sterilnoj vati, stavljeni u sterilnu plastičnu epen-
dorf epruvetu i zamrzavani na -70oC. Homogenizacija je vršena 
teflonskim tučkom u ledenom fosfatnom puferu pH 7,4 čija je 
zapremina prilagođena težini tkiva, tako da finalna koncentra-
cija homogenata iznosi 10%. Krupniji detritus je sedimentiran 
centrifugiranjem na 1400 obrtaja tokom 1 minuta na -40C. Su-
pernatant je nakon toga smrznut na -70oC do izvođenja odgo-
va rajućih biohemijskih analiza.
Koncentracija IL-6 je određivana ELISA testom (R&D Systems 
Inc. Minneapolis, USA) prema uputstvu proizvođača. Senzitivnost 
ELISA testa za IL-6 je iznosila od 0,7 pg/ml, a koncentracija je 
analizirana u odnosu na simptomatologiju i veličinu lezije. Sta-
tistička analiza je urađena pomoću Mann–Whitney Rank Sum 
testa korišćenjem programa Sigmastat i Origin. Rezultati su izra-
ženi kao srednje vrednosti ± standardna devijacija. Statistički 
zna čajnim razlikama su sma trane one koje su bile pri p < 0,05.
REZULTATI
Ispitivanje koncentracije IL-6 u homogenatima uzoraka tkiva 
periapeksnih lezija je pokazalo značajnu koncentraciju citoki-
na u svim uzorcima. Na Slici 1 prikazana je koncentracija IL-6 
u homogenatima tkiva svih uzoraka, analiziranim u odnosu na 
simptomatologiju i veličinu. U grupi simptomatskih lezija pro-
sečna koncentracija IL-6 je iznosila 975,51 pg/ml, dok je u grupi 
asimptomatskih lezija prosečna vrednost bila 212,04 pg/ml. Ana-
lizom koncentracija ustanovljeno je da postoji statistički značajno 
veća koncentracija IL-6 u simptomatskim lezijama (p < 0,001). U 
grupi veli kih lezija prosečna koncentracija IL-6 je iznosila 687,14 
pg/ml, dok je u grupi malih lezija prosečna vrednost bila 470,92 
pg/ml. Razlika je postojala, ali nije bila statistički značajna.
U Tabeli 2 prikazane su vrednosti koncentracije IL-6 u 
okviru grupa simptomatskih i asimptomatskih lezija, a kon-
centracija citokina je u svakoj od grupa analizirana u odnosu 
na veličinu. Prosečna koncentracija IL-6 u simptomatskim veli-
kim lezijama je iznosila 1162,40 pg/ml, dok je u simptomatskim 
malim lezijama koncentracija IL-6 iznosila 759,11 pg/ml. Nije 
zapažena statistički značajna razlika u koncentracijama IL-6 u 
grupi simptomatskih lezija u odnosu na veličinu. U grupi asimp-
tomatskih lezija, takođe, nije ustanovljena statistički značajna 
koncentracija u odnosu na veličinu. Prosečna koncentracija IL-6 
kod asimpto mat skih velikih lezija je iznosila 189,24 pg/ml, dok 
je kod asimptomatskih malih lezija iznosila 232,86 pg/ml.
Na Slici 2 prikazana je koncentracija IL-6 u okviru grupa 
velikih i malih lezija, gde je statistička značajnost analizirana u 
odnosu na simptomatologiju. Prosečna koncentracija IL-6 kod 
velikih simptomatskih lezija je iznosila 1162,40 pg/ml, dok je 
kod velikih asimptomatskih iznosila 189,24 pg/ml. Ustanovljena 
razlika je bila statistički značajna (p < 0,001). Analiza je pokaza-
la i statistički značajno veću koncentraciju u malim simpto mat-
skim lezijama (759,11 pg/ml) u odnosu na male asimptomatske 
(232,86 pg/ml) (p < 0,05).
DISKUSIJA
Periapeksne lezije nastaju kao rezultat perzistentnog inflama-
tornog odgovora indukovanog prolongiranom izloženošću pe-
riapeksnih tkiva mikroorganizmima kanala korena, što izaziva 
imunološku reakciju. U ovom lokalnom mehanizmu odbrane 
različiti inflamatorni medija tori igraju složenu i centralnu 
ulogu u regulisa nju imunog odgovora. Dok proinflamatorni 
citokini, kao što su IL-1, IL-6, TNF-α, TNF-β, hemokini i Th1 
citokini, propagiraju inflamaciju u periapeksnim tkivima i ak-
tiviraju osteoklastnu koštanu resorpciju [10, 11], uloga antiin-
flamatornih citokina je važna za supresiju inflamatornih pro-
cesa i procese zarastanja unutar periapeksnih lezija [2, 3, 12].
U ranoj inflamatornoj kaskadi stvaranje IL-6 indukuju IL-1 i 
TNF-α. IL-6 ima mnoge molekularne forme i svaki molekul ima 
drugačiju funkciju kada ga sekretuju različite ćelije u različitim 
situa ci jama. Nalaz da polimorfonuklearne ćelije u periapeksnim 
tkivima produkuju IL-6, što je navedeno od strane Eulera i sa-
radnika [13], ukazuje da IL-6 može doprineti tkivnoj povredi 
na mestu inflamacije. IL-6 predstavlja integralni medijator u 
akutnoj fazi odgovora na povredu i infekciju kada stimuliše 
ekspresiju proteina akutne faze [14]. Ispitivanje različitih ci-
tokina, kao što su TNF-α, IL-6, IL-3, GM-CSF, IL-11, IL-17, IL-
18, na humanim i animalnim modelima pokazala su njihovu 
potencijalnu ulogu u patogenezi osteolitičkih oboljenja [2, 15]. 
Dokazano je da inflamatorni citokini IL-6 i TNF-α imaju kapa-
citet da aktiviraju osteoklastnu koštanu resorpciju, a svoju ulogu 
mogu da ostvaruju sinergistički sa IL-1, izazivajući aktivaciju 
ili diferencijaciju osteoklasta i produkciju, odnosno sekreciju 
prosta glan dina od strane brojnih ćelijskih tipova, uključujući fi-
broblaste i osteoblaste [2]. Više autora je objavilo ekspresiju IL-6 
u humanim periapeksnim granulomima i cistama. Rezultati ove 
studije su dokazali prisustvo IL-6 u svim tkivnim uzorcima pe-
riapeksnih lezija, što je u skladu sa podacima iz literature [9, 16]. 
Istraživanja su pokazala da je nivo IL-6 značajno povećan 
kod infekcija i bolnih stanja. U studiji De Jongh i saradnika 
[17] važna uloga je pripisana IL-6 u patofiziologiji bola. Zbog 
te činjenice, u ovoj studiji je analizirana korelacija između nivoa 
IL-6 i simptomatologije. Rezultati ovog istraživanja su ukazali 
na statistički značajno veću produkciju IL-6 u simptomatskim 
lezijama u odnosu na asimpto matske, dok je prosečna koncen-
tracija ovog citokina bila veća u velikim lezijama u odnosu na 
male, ali ova razlika nije bila statistički značajna.
U istraživanju Gazivode i saradnika [18] uočena je jača pro-
dukcija IL-6 u simptomatskim i velikim lezijama, naglašavajući 
pre svega njegov proinflamatorni aspekt u ovom oboljenju. Me-
đutim, eksperimenti na IL-6 deficitnom mišu pokazuju suprotne 
rezultate, ukazujući na efekat zaštite ovog citokina od koštane 
destrukcije [14]. Ove razlike mogu se objasniti činjenicom da IL-6 
poseduje i proinflamatorne i antiin fla matorne osobine i da njegov 
krajnji efekat zavisi od ciljnih ćelija i sadejstva drugih citokina.
Inflamatorne reakcije kod pacijenata sa apeksnim paro-
dontitima nisu ograničene samo na periradiksnu regiju [19]. 
Poznato je da dentalne infekcije mogu imati negativni uticaj 
na opšte zdravlje kod pacijenata sa rizikom [20]. Analiza krvi 
pacijenata nakon endodontske terapije zuba sa apeksnim pa-
rodontitima je pokazala prisustvo bakterija za koje je dokazano 
da vode poreklo iz kanala korena [21]. Širenje oralnih bakte-
rija putem krvotoka nije jedini put za posredova nje u ciljanim 
efektima oralnih fokalnih infekcija. Mnogo značajniji uticaj na 
funkciju uda ljenih tkiva i organa može biti izazvan pojedinim 
citokinima. Iako većina članova super fa milije citokina ispoljava 
kratkotrajne efekte, IL-1, IL-6 i TNF su pokazali da, lokalno 
produ kovani unutar tkiva periapeksnih granuloma, mogu biti 
nošeni putem krvotoka do udaljenih mesta. Ovi citokini mogu 
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da izazovu akutnu fazu odgovora koji podrazumeva povišenu 
telesnu temperaturu, povećanu sedimentaciju eritrocita i pro-
menu u serum skim proteinima sinte tisanih od strane hepato-
cita. Pojedini autori su pratili povećane nivoe proteina akutne 
faze kod pacijenata sa hroničnim periapeksnim granulomima. 
Njihov nivo je snižen na normalne vrednosti nakon hirurškog 
uklanjanja lezije apikotomijom [10, 22].
ZAKLJUČAK
Veća koncentracija IL-6 u lezijama sa izraženim kliničkim 
simptomima, kao i velikim lezijama, ukazuje na njegovu važnu 
proinflamatornu aktivnost i ključnu ulogu snažnog medijatora 
koji je odgovoran za progresiju lezije i stimulaciju koštane re-
sorpcije u patogenezi periapeksnih lezija.
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